R

Rafael Holdings
D

RFL

1.97000
USD
0.06
(3.14%)
مفتوح الان
حجم التداول
440
الربح لكل سهم
0
العائد الربحي
-
P/E
-2
حجم السوق
69,150,337
أصول ذات صلة
CAT
CAT
-6.82
(-1.71%)
391.98 USD
CMI
CMI
-0.99
(-0.30%)
328.43 USD
DE
DE
-10.71
(-2.05%)
510.80 USD
DOV
DOV
-1.970
(-1.04%)
186.560 USD
GE
GE
0.320
(0.13%)
247.280 USD
HON
HON
-1.740
(-0.72%)
238.990 USD
IR
IR
-1.150
(-1.31%)
86.390 USD
MMM
MMM
-0.970
(-0.64%)
151.300 USD
PNR
PNR
-1.210
(-1.14%)
104.790 USD
SWK
SWK
-0.620
(-0.88%)
69.810 USD
المزيد
الأخبار المقالات

العنوان: Rafael Holdings

القطاع: Real Estate
الصناعة: Real Estate Services
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.